Overview
Veracyte develops genomic diagnostic tests that help physicians make more accurate diagnoses and better-informed treatment decisions in thyroid cancer, lung cancer, and other difficult-to-diagnose conditions.
More in Clinical Diagnostics
Latest industry news
At-Home DNA Tests: What They Can and Can't Tell You About Inherited Health Risks
2026-09-09 · Industry
Carla Walker Act Targets Cold Case DNA Funding Gap as Forensic Genomics Gains Legislative Momentum
2026-09-08 · Policy
Roche Korea Recognized for Advancing Cancer Precision Medicine as Oncogenomics Gains Regional Momentum
2026-09-07 · Industry
Guardant Health Jumps 25% After FDA Clears First Genomic-Epigenomic Liquid Biopsy Panel
2026-09-06 · Product
Company details
Category
🏥 Clinical Diagnostics
Location
San Francisco, California, USA
Funding
Publicly traded on NASDAQ: VCYT; raised over $500 million through public offerings and partnerships
Website
www.veracyte.comListed
2026-07-20
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →